Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	125.74	78.97	34.98
Graham Fair Price	-30.78	2.34	3.38
PEG	-51.71	-0.68	1.40
Price/Book	-8.32	0.99	1.08
Price/Cash Flow	-47.98	-2.94	5.64
Prices/Earnings	119.54	37.69	17.17
Price/Sales	-51.24	2.28	4.68
Price/FCF	-47.98	-2.94	5.64
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-38.67	0.10	0.17
Operating Margin	-57.94	0.02	0.04
ROA	-60.59	< 0.005	< 0.005
ROE	0.02	< 0.005	-58.24
ROIC	< 0.005	< 0.005	-43.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.84	0.05	1600.72
Dividends QOQ	0.38	0.68	78.15
EBIT QOQ	15.85	-0.20	-98.71
EPS QOQ	0.12	-0.56	354.65
FCF QOQ	1.57	-2.77	76.99
Revenue QOQ	-0.32	0.89	180.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	281.04	153.06	-45.54
Days Sales Outstanding (DSO)	65.18	42.57	-34.70
Inventory Turnover	0.32	0.59	83.62
Debt/Capitalization	0.26	0.39	50.70
Quick Ratio	0.58	0.72	24.87
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.68	6.09	7.12
Cash	3.21	3.12	-2.75
Capex	-0.64	-1.73	-170.94
Free Cash Flow	1.09	-2.05	88.80
Revenue	1.31	2.64	101.40
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.12	1.48	32.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.02	8.25	-8.49
Naive Interpretation	Member

06 - Financial Health · Weak

Rating